Clinical Trial Update: Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate converting to lacosamide monotherapy for partial-onset seizures, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2014-04-23